Praziquantel Treatment in Trematode and Cestode Infections: An Update

키워드

참고문헌 (96)

1. Andrews P, "Praziquantel", Medl Res Rev, 3, pp.147~200 (1983)
2. Lee SH, "Praziquantel in the treatment of trematodeand cestode infections", J Korean Soc Chemother, 3, pp.95~118 (1985)
3. Keiser J, "Chemotherapy for major foodbornetrematodes: a review", Expert Opin Pharmacother, 5, pp.1711~1726 (2004)
4. Chan JD, "Ca(2+) channelsand Praziquantel: A view from the free world", Parasitol Int, pp.S1383~S5769 (2012)
5. Wang W, "Susceptibility or resistance ofpraziquantel in human schistosomiasis: a review", ParasitolRes, 111, pp.1871~1877 (2012)
6. Tinga N, "Little effect of praziquantel or artemisinin on clonorchiasisin Northern Vietnam. A pilot study", Trop Med Int Health, 4, pp.814~818 (1999)
7. 경선영, "A Paragonimiasis Patient with Allergic Reaction to Praziquantel and Resistance to Triclabendazole: Successful Treatment after Desensitization to Praziquantel", The Korean Journal of Parasitology, 49(1), pp.73~77 (2011), 대한기생충학회
8. Jung-Min Lee, "Hypersensitive Reaction to Praziquantel in a Clonorchiasis Patient", The Korean Journal of Parasitology, 49(3), pp.273~275 (2011), 대한기생충학회
9. Pax R, "A benzodiazepine derivative and praziquantel: effects on musculature of Schistosomamansoni and Schistosoma japonicum", Arch Pharmacol, 304, pp.309~315 (1978)
10. Becker B, "Lightand electron microscopic studies on the effect of praziquantelon Schistosoma mansoni, Dicrocoelium dendriticum,and Fasciola hepatica (Trematoda) in vitro", Z Parasikentd, 63, pp.113~128 (1980)
11. Mehlhorn H, "In vivo and in vitro experiments on the effects of praziquantelon Schistosoma mansoni", Arzneimittelfurschung, 31, pp.544~554 (1981)
12. Mehlhorn H, "Ultrastructural investigations on theeffects of praziquantel on human trematodes from Asia:Clonorchis sinensis, Metagonimus yokogawai, Opisthorchisviverrini, Paragonimus westermani and Schistosomajaponicum", Arzneimittelforschung, 33, pp.91~98 (1983)
13. Lee SH, "In vitro effects of praziquantel on Fibricola seoulensis", Seoul J Med, 26, pp.41~52 (1985)
14. Rim HJ, "Morphological observationson Clonorchis sinensis obtained from rats treated withpraziquantel", Kisaengchunghak Chapchi, 18, pp.192~198 (1980)
15. Seo BS, "Studies on intestinaltrematodes in Korea XIX. Light and scanning electronmicroscopy of Fibricola seoulensis collected from albinorats treated with praziquantel", Kisaengchunghak Chapchi, 23, pp.47~57 (1985)
16. Lee SH, "In vitro effectof praziquantel on Paragonimus westermani by light andscanning electron microscopic observation", KisaengchunghakChapchi, 25, pp.24~36 (1987)
17. Chiu HS, "Electron-microscopic studies onthe effect of praziquantel to Paragonimus westermani", KoreaUniv Med J, 19, pp.617~630 (1982)
18. Horchner F, "Die Wirkung von Mebendazoleund Praziquantel auf larvale Taenienstadien bei Maus,Kaninchen und Schwein", Tropenmed Parasit, 28, pp.44~50 (1976)
19. Thomas H, "The efficay of praziquantel againstcestodes in animals", Z Parasitenkd, 52, pp.117~127 (1977)
20. Becker B, "Thomas H. Scanning andtransmission electron microscope studies on the efficacyof praziquantel on Hymenolepis nana (Cestoda) in vitro", ZParasikentd, 61, pp.121~133 (1980)
21. Becker B, "Ultrastructuralinvestigations on the effect of praziquantel on the tegument of five species of cestodes", Z Parasikentd, 64, pp.257~269 (1981)
22. Bylund G, "Tests with a new compound(Praziquantel) against Diphyllobothrium latum", J Helminthol, 51, pp.115~119 (1977)
23. Thomas H, "The efficacy of praziquantel againstexperimental cysticercosis and hydatidosis (author'stransl)", Z Parasitenkd, 55, pp.165~179 (1978)
24. Geary TG, "Unresolved issues in anthelminticpharmacology for helminthiases of humans", Int J Parasitol, 40, pp.1~13 (2010)
25. Vok al I, "The inability of tapewormHymenolepis diminuta and fluke Dicrocoelium dendriticumto metabolize praziquantel", Vet Parasitol, 185, pp.168~174 (2012)
26. Jeziorski MC, "Voltage-gated calcium channelsubunits from platyhelminths: potential role in praziquantelaction", Int J Parasitol, 36, pp.625~632 (2006)
27. Angelucci F, "The anti-schistosomal drug praziquantel is an adenosineantagonist", Parasitology, 134, pp.1215~1221 (2007)
28. Doenhoff MJ, "Praziquantel: mechanismsof action, resistance and new derivatives for schistosomiasis", Curr Opin Infect Dis, 21, pp.659~667 (2008)
29. Coulibaly JT, "Efficacy and safety of praziquantel in preschoolagedchildren in an area co-endemic for Schistosoma mansoniand S. haematobium", PLoS One, 6, pp.e1917~ (2012)
30. Lovis L, "Efficacy of praziquantelagainst Schistosoma mekongi and Opisthorchis viverrini:a randomized, single-blinded dose-comparison trial", PLoSOne, 6, pp.e1726~ (2012)
31. Seto EY, "Human schistosomiasisresistance to praziquantel in China: should we be worried", Am J Trop Med Hyg, 85, pp.74~82 (2011)
32. Lee SH, "Large scale treatment of Clonorchis sinensis infectionswith praziquantel under field conditions", Arzneimittelforschung, 34, pp.1227~1230 (1984)
33. Bunnag D, "Studies on the chemotherapyof human opisthorchiasis: III. Minimum effective dose ofpraziquantel", Southeast Asian J Trop Med Public Health, 12, pp.413~417 (1981)
34. Zavo kin VD, "Theprocedure for the wide use of praziquantel in a complex ofmeasures to control opisthorchiasis. 1. The tolerance andefficacy of different doses of biltricide during outpatient usein foci", Med Parasitol (Mosk), (3), pp.24~27 (1994)
35. Rim HJ, "Chemotherapeutc effect of praziquantel(Embay 8440) in the treatment of clonorchiasis sinensis", Korea Univ Med J, 16, pp.459~470 (1979)
36. Wegner DH, "The profile of the trematodicidal compoundpraziquantel", Arzneimittelforschung, 34, pp.1132~1136 (1984)
37. Farag HF, "A short note on praziquantel in human fascioliasis", J Trop Med Hyg, 89, pp.79~80 (1986)
38. Farid Z, "Praziquantel and Fasciolahepatica infection", Trans R Soc Trop Med Hyg, 83, pp.813~ (1989)
39. Keiser J, "Triclabendazolefor the treatment of fascioliasis and paragonimiasis", ExpertOpin Investig Drugs, 14, pp.1513~1526 (2005)
40. Rim HJ, "Chemotherapeutic effect of niclofolanand praziquantel in the treatment of paragonimiasis", KoreaUniv Med J, 17, pp.113~128 (1980)
41. Udonsi JK, "Clinical field trials of praziquantel in pulmonaryparagonimiasis due to Paragonimus uterobilateralis in endemicpopulations of the Igwun Basin", Trop MedParasitol, 40, pp.65~68 (1989)
42. Bunnag D, "Field trial on thetreatment of fasciolopsiasis with praziquantel", SoutheastAsian J Trop Med Public Health, 14, pp.216~219 (1983)
43. Hong ST, "Fifteenhuman cases of Fibricola seoulensis infection in Korea", KisaengchunghakChapchi, 22, pp.61~65 (1984)
44. Lee SK, "An epidemiological survey of Echinostoma hortenseinfection in Chongsong-gun, Kyongbuk Province", KisaengchunghakChapchi, 26, pp.199~206 (1988)
45. Lee SH, "High prevalence of Gymnophalloides seoiinfection in a village on a southwestern island of the Republic of Korea", Am J Trop Med Hyg, 51, pp.281~285 (1994)
46. Chai JY, "The first discovery of anendemic focus of Heterophyes nocens (Heterophyidae) infectionin Korea", Korean J Parasitol, 32, pp.157~161 (1994)
47. Chai JY, "Acanthoparyphiumtyosenense: the discovery of human infection andidentification of its source", J Parasitol, 87, pp.794~800 (2001)
48. Rim HJ, "Therapeutic effects of praziquantel(Embay 8440) against Taenia solium infection", Kisaengchunghak Chapchi, 17, pp.67~72 (1979)
49. Chai JY, "Anthelminticeffect of praziquantel (Cestocide@) in the treatment ofTaenia saginata and Diphyllobothrium latum infection", JKorean Soc Chemother, 3, pp.181~184 (1985)
50. Schenone H, "Treatment of Hymenolepis nana infection in children bya single oral dose of praziquantel (Embay 8440)", Bol ChileParasitol, 32, pp.11~13 (1977)
51. Rim HJ, "Therapeutic effectsof praziquantel (Embay 8440) against Hymenolepis nanainfection", Kisaengchunghak Chapchi, 16, pp.82~87 (1978)
52. Schenone H, "Praziquantel in the treatment of Hymenolepisnana infection in children", Am J Trop Med Hyg, 29, pp.320~321 (1980)
53. Rim HJ, "Treatment of Hymenolepis nana infection", 박사, pp.1981
54. Park CY, "Clinical observation on the chemotherapyof cerebral cysticercosis", Korea Univ Med J, 19, pp.595~616 (1982)
55. Sotelo J, "Therapy of parenchymal brain cysticercosiswith praziquantel", New Eng J Med, 310, pp.1001~1007 (1984)
56. del Brutto OH, "Albendazole therapy for subarachnoidand ventricular cysticercosis. Case report", J Neurosurg, 72, pp.816~817 (1990)
57. Takayanagui OM, "Medical management of neurocysticercosis", ExpertOpin Pharmacother, 12, pp.2845~2856 (2011)
58. Santos R, "Failure of medical treatmentin two cases of intraocular cysticerscosis", Am J Ophthalmol, 97, pp.249~250 (1984)
59. Chai JY, "Ineffectiveness ofpraziquantel treatment for human sparganosis: a case report", Seoul J Med, 29, pp.397~399 (1988)
60. Sohn WM, "Infectivity of the sparganumtreated by praziquantel, gamma-irradiation andmechanical cutting", Korean J Parasitol, 31, pp.135~139 (1993)
61. Tanaka S, "A case of pleuralsparganosis", Parasitol Int, 46, pp.73~75 (1997)
62. Ishii H, "A rare case of eosinophilic pleuritis due to sparganosis", Intern Med, 40, pp.783~785 (2001)
63. 이주희, "A Case of Sparganosis That Presented as a Recurrent Pericardial Effusion", Korean Circulation Journal, 41(1), pp.38~42 (2011), 대한심장학회
64. Haralabidis S, "Long-termevaluation of patients with hydatidosis treated with albendazoleand praziquantel", Int J Immunopathol Pharmacol, 21, pp.429~435 (2008)
65. Tekin R, "Cardiac hydatid cystcase recovered with medical treatment", Anadolu KardiyolDerg, 11, pp.650~651 (2011)
66. Shaw JG, "Reduction in hookworm infection after praziquanteltreatment among children and young adults in Leyte, thePhilippines", Am J Trop Med Hyg, 83, pp.416~421 (2010)
67. Mehlhorn H, "Light andelectron microscopic studies on Schistosoma mansonigranulomas of mouse livers following treatment with praziquantel", Tropenmed Parasitol, 33, pp.229~239 (1982)
68. Cheever AW, "Persistence of hepatic fibrosis and tissueeggs following treatment of Schistosoma japonicuminfected mice", Am J Trop Med Hyg, 40, pp.620~628 (1989)
69. Cheever AW, "Persistence of eggs and hepatic fibrosis after treatmentof Schistosoma mansoni-infected mice", Am J Trop MedHyg, 46, pp.752~758 (1992)
70. Lee SH, "Observationof liver pathology after praziquantel treatment inexperimental Clonorchis sinensis infection in guinea pigs", Seoul J Med, 29, pp.253~262 (1988)
71. Lee SH, "Histopathologicalchanges of the liver after praziquantel treatmentin Clonorchis sinensis infected rabbits", KisaengchunghakChapchi, 25, pp.110~122 (1987)
72. Lee SH, "Effect of praziquantel treatment on pulmonary lesionsof rats infected with Paragonimus iloktsuenensis", KisaengchunghakChapchi, 27, pp.119~130 (1989)
73. Lee SH, "Observation ofmucosal pathology after praziquantel treatment in experimentalFibricola seoulensis infection in rats", KisaengchunghakChapchi, 27, pp.35~40 (1989)
74. Gustowska L, "Histopathological and histoenzymaticstudies on experimental Taenia saginata cysticercosis", Vet Parasitol, 8, pp.211~218 (1981)
75. Hong ST, "Sustained-release praziquantel tablet: pharmacokineticsand the treatment of clonorchiasis in beagle dogs", Parasitol Res, 91, pp.316~320 (2003)
76. Lei L, "Prevention of Schistosoma japonicum infection in micewith long-acting praziquantel implants", Exp Parasitol, 131, pp.442~447 (2012)
77. Rim HJ, "The current pathobiology and chemotherapy ofclonorchiasis", Kisaengchunghak Chapchi, 24, pp.1~141 (1986)
78. Huang SW, "A clinical approach to a patient with praziquantelhypersensitivity", J Allergy Clin Immunol, 90, pp.867~ (1992)
79. Shen C, "A case ofanaphylactic reaction to praziquantel treatment", Am J TropMed Hyg, 76, pp.603~605 (2007)
80. Adam I, "Is praziquantel therapysafe during pregnancy", Trans R Soc Trop Med Hyg, 98, pp.540~543 (2004)
81. Adam I, "Praziquantel for the treatmentof schistosomiasis mansoni during pregnancy", AnnTrop Med Parasitol, 99, pp.37~40 (2005)
82. Liang YS, "Adultworm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansonitreated in vivo", J Helminthol, 76, pp.327~333 (2002)
83. Liang YS, "Susceptibility to praziquantelof male and female cercariae of praziquantel-resistantand susceptible isolates of Schistosoma mansoni", J Helminthol, 84, pp.202~207 (2010)
84. Wang W, "Susceptibility or resistance ofpraziquantel in human schistosomiasis: a review", ParasitolRes, 111, pp.1871~1877 (2012)
85. Fallon PG, "Drug-resistant schistosomiasis:resistance to praziquantel and oxamniquine induced inSchistosoma mansoni in mice is drug specific", Am J TropMed Hyg, 51, pp.83~88 (1994)
86. Couto FF, "Schistosoma mansoni: a methodfor inducing resistance to praziquantel using infectedBiomphalaria glabrata snails", Mem Inst Oswaldo Cruz, 106, pp.153~157 (2011)
87. Fallon PG, "Shortreport: diminished susceptibility to praziquantel in a Senegalisolate of Schistosoma mansoni", Am J Trop Med Hyg, 53, pp.61~62 (1995)
88. Ismail M, "Characterization of isolates of Schistosoma mansonifrom Egyptian villages that tolerate high doses of praziquantel", Am J Trop Med Hyg, 55, pp.214~218 (1996)
89. Alonso D, "Failureof standard treatment with praziquantel in two returnedtravelers with Schistosoma haematobium infection", Am JTrop Med Hyg, 74, pp.342~344 (2006)
90. Keiser J, "The drugs we have and the drugs weneed against major helminth infections", Adv Parasitol, 73, pp.197~230 (2010)
91. Lateef M, "Successfultreatment of niclosamide- and praziquantel-resistantbeef tapeworm infections with nitazoxanide", Int J Infect Dis, 12, pp.80~82 (2008)
92. Rim HJ, "Anthelminticeffects of various drugs against metagonimiasis", KisaengchunghakChapchi, 16, pp.117~122 (1978)
93. Lee SH, "Anthelminti effect of praziquantel (Distocide®) against Metagonimus yokogawaiinfection", J Korean Soc Chemother, 2, pp.167~171 (1984)
94. el-Hawy AM, "The cure rates of patients infected with heterophyiasis andtreated with praziquantel versus niclosamide", J Egypt SocParasitol, 18, pp.437~442 (1988)
95. Ata AA, "Theeffect of praziquantel on Heterophyes heterophyes, Hymenolepisnana and Fasciola sp. infections", J Egypt Soc Parasitol, 18, pp.243~246 (1988)
96. Pungpak S, "Treatment of Opisthorchis viverriniand intestinal fluke infections with Praziquantel", SoutheastAsian J Trop Med Public Health, 29, pp.246~249 (1998)

관련 논문AI추천